Treatment patterns in geriatric patients with melanoma and the effect of age on the efficacy of immunotherapy: Analysis from the real-world multicenter registry ADOREG
Konstantinos Lallas(Aristotle University of Thessaloniki), Ulrike Leiter(University of Tübingen), Ralf Gutzmer(University Hospitals of the Ruhr-University of Bochum), Christoffer Gebhardt(Universität Hamburg), Uwe Hillen(University of Duisburg-Essen), Anja Gesierich(University of Michigan), Michael Weichenthal(Christian-Albrechts-Universität zu Kiel), Andrea Forschner(University of Tübingen), Elisabeth Livingstone(German Cancer Research Center), Martin Kaatz(SRH Wald-Klinikum Gera), Lena Nanz(University Children's Hospital Tübingen), Jens Ulrich, Julia Welzel(University Hospital Augsburg), Lisa Zimmer(Essen University Hospital), Dirk Schadendorf(Düsseldorf University Hospital), Peter Mohr(Elbe Kliniken Stade-Buxtehude), Patrick Terheyden(University of Lübeck), Imke von Wasielewski(Medizinische Hochschule Hannover), Sebastian Haferkamp(University Hospital Regensburg), Thilo Gambichler(Ruhr University Bochum), Frank Meiss(University Medical Center Freiburg), Carola Berking(Friedrich-Alexander-Universität Erlangen-Nürnberg), Jessica Hassel(Heidelberg University), Alexander Kreuter(HELIOS St. Elisabeth Klinik Oberhausen), Claudia Pföhler(Saarland University), Selma Ugurel(Klinikum Bielefeld), Lukas Flatz(University Children's Hospital Tübingen), Friedegund Meier(University Hospital Carl Gustav Carus), Rudolf Herbst(Helios Klinikum Erfurt)
Cited by 0
Related Papers
Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
|The Lancet|2012|3k
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
|New England Journal of Medicine|2018|1.9k
Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways
|Nature Genetics|2009|1.4k
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
|New England Journal of Medicine|2017|1.4k